Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinase. (Q40951663)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Asterriquinones produced by Aspergillus candidus inhibit binding of the Grb-2 adapter to phosphorylated EGF receptor tyrosine kinase (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

0 references

1 reference

[4-hydroxy-2,5-bis[[2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]-3,6-dioxocyclohexa-1,4-dien-1-yl] acetate

1 reference

Asterriquinone SU-5228

1 reference

2,5-Dihydroxy-3,6-bis[[1-(2-methylbut-3-en-2-yl)indol-3-yl]methyl]cyclohexa-2,5-diene-1,4-dione

1 reference

2,5-dihydroxy-3,6-bis[[2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]cyclohexa-2,5-diene-1,4-dione

1 reference

1 reference

Asterriquinone SU-5503

1 reference

2,5-dihydroxy-3-(1H-indol-3-ylmethyl)-6-[[2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]cyclohexa-2,5-diene-1,4-dione

1 reference

3-[[2,5-dihydroxy-4-[[2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]-3,6-dioxocyclohexa-1,4-dien-1-yl]methyl]-2-(3-methylbut-2-enyl)-1H-indole-7-carboxylic acid

1 reference

Asterriquinone SU-5501

1 reference

2,5-dihydroxy-3-[1-(2-methylbut-3-en-2-yl)indol-3-yl]-6-[7-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]cyclohexa-2,5-diene-1,4-dione

1 reference

Asterriquinone SU-5500

1 reference

K A Alvi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Pu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Luche

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

A Rice

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H App

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

G McMahon

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

H Dare

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

B Margolis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

1 reference

1999

1 reference

Crossref

full work available at URL

16 September 2022

https://www.jstage.jst.go.jp/article/antibiotics1968/52/3/52_3_215/_pdf

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.52.215?email=unpaywall_01@example.com

published in

The Journal of Antibiotics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

215-223

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

19 March 2024

https://api.unpaywall.org/v2/10.7164/antibiotics.52.215?email=unpaywall_01@example.com

access restriction status

open access

1 reference

based on heuristic

inferred from online access status

cites work

Design of peptidomimetic ligands for the pp60src SH2 domain

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Isolation and biological activities of signal transduction inhibitors from microorganisms and plants

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Nonphosphorylated peptide ligands for the Grb2 Src homology 2 domain

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

SH2 domain protein interaction and possibilities for pharmacological intervention

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411

1 reference

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

Four new metabolites of Aspergillus terreus

2 references

12 April 2024

https://opencitations.net/index/api/v1/references/10.7164/ANTIBIOTICS.52.215

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1248/CPB.42.1682

Identifiers

DOI

10.7164/ANTIBIOTICS.52.215

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10348035%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference